𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Phase I/II Study Of Cyclophosphamide and Topotecan In Patients With High-Risk Malignancies Undergoing Autologous Hematopoietic Stem Cell Transplantation: The St. Jude Long-Term Follow-Up

✍ Scribed by K.A. Kasow; R.C. Barfield; N.L. Wright; C. Li; D.K. Srivastava; E.M. Horwitz; W. Leung; P. Woodard; L.C. Bowman; R. Handgretinger; G.A. Hale

Book ID
116280732
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
82 KB
Volume
15
Category
Article
ISSN
1083-8791

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Long-term follow-up of a phase I study o
Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias
✍ Marcos de Lima; Farhad Ravandi; Munir Shahjahan; Borje Andersson; Daniel Couriel πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 77 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Decitabine is a hypomethylating agent that has activity in patients with leukemia. The authors combined decitabine with busulfan and cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic stem cell transplantation. ## METHODS Patients with high‐ris